GF

Gordon J. Freeman

DI Dana-Farber Cancer Institute: 87 patents #2 of 1,343Top 1%
Harvard University: 25 patents #38 of 3,600Top 2%
BH Brigham and Women's Hospital: 16 patents #20 of 1,764Top 2%
NA Novartis Ag: 13 patents #212 of 5,128Top 5%
EU Emory University: 11 patents #34 of 1,217Top 3%
GI Genetics Institute: 11 patents #30 of 327Top 10%
CC Children'S Medical Center: 7 patents #73 of 1,211Top 7%
Stanford University: 4 patents #598 of 5,197Top 15%
RE Repligen: 3 patents #23 of 102Top 25%
Pfizer: 2 patents #2,078 of 5,153Top 45%
UP University of Pennsylvania: 2 patents #743 of 2,719Top 30%
BC Beth Israel Deaconess Medical Center: 2 patents #158 of 672Top 25%
TH The Children'S Hospital: 1 patents #11 of 49Top 25%
University of Michigan: 1 patents #1,906 of 4,352Top 45%
UB University Of Maryland, Baltimore: 1 patents #465 of 1,115Top 45%
UF US Air Force: 1 patents #6,190 of 16,312Top 40%
UM University Of Maryland: 1 patents #209 of 857Top 25%
TH The Brigham And Woman'S Hospital: 1 patents #1 of 37Top 3%
📍 Brookline, MA: #11 of 3,196 inventorsTop 1%
🗺 Massachusetts: #324 of 88,656 inventorsTop 1%
Overall (All Time): #17,696 of 4,157,543Top 1%
90
Patents All Time

Issued Patents All Time

Showing 26–50 of 90 patents

Patent #TitleCo-InventorsDate
10457733 Agents that modulate immune cell activation and methods of use thereof Arlene H. Sharpe, Yanping Xiao, Loise M. Francisco, Rosemarie Dekruyff, Dale T. Umetsu 2019-10-29
10370448 Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor Rafi Ahmed, Timothy David Jones, Francis Joseph Carr, James P. Gregson 2019-08-06
10370446 Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway Arlene H. Sharpe, David M. Dorfman, Rafi Ahmed, Daniel Barber, E. John Wherry 2019-08-06
10202454 Anti-PD-L1 monoclonal antibodies and fragments thereof Arlene H. Sharpe 2019-02-12
10011656 Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor Rafi Ahmed, Timothy David Jones, Francis Joseph Carr, James P. Gregson 2018-07-03
9988452 Antibody molecules to PD-L1 and uses thereof Arlene H. Sharpe, Gerhard Frey, Hwai Wen Chang, Jennifer Marie Mataraza, Glenn Dranoff 2018-06-05
9962440 Methods related to TIM 3, a TH1-specific cell surface molecule, for activating antigen presenting cells Vijay K. Kuchroo, Sumone Chakravarti, Catherine Anne Sabatos-Peyton 2018-05-08
9884913 Antibody molecules to TIM-3 and uses thereof Catherine Anne Sabatos-Peyton, Barbara Brannetti, Alan S. Harris, Thomas Huber, Thomas Pietzonka +9 more 2018-02-06
9845356 Single agent anti-PD-L1 and PD-L2 dual binding antibodies and methods of use Arlene H. Sharpe 2017-12-19
9815898 Antibody molecules to PD-1 and uses thereof Arlene H. Sharpe, Walter A. Blattler, Jennifer Marie Mataraza, Catherine Anne Sabatos-Peyton, Hwai Wen Chang +1 more 2017-11-14
9683049 Modulation of TIM receptor activity in combination with cytoreductive therapy Jennifer Jones, Rosemarie Dekruyff, Dale T. Umetsu, Susan Knox 2017-06-20
9683048 Antibody molecules to PD-1 and uses thereof Arlene H. Sharpe, Walter A. Blattler, Jennifer Marie Mataraza, Catherine Anne Sabatos-Peyton, Hwai Wen Chang +1 more 2017-06-20
9605070 Antibody molecules to TIM-3 and uses thereof Catherine Anne Sabatos-Peyton, Barbara Brannetti, Alan S. Harris, Thomas Huber, Thomas Pietzonka +9 more 2017-03-28
9598491 Methods for the treatment of infections and tumors Rafi Ahmed, Rama Rao Amara, Vijayakumar Velu, Kehmia Titanji 2017-03-21
9457080 Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway Arlene H. Sharpe, David M. Dorfman, Rafi Ahmed, Daniel Barber, E. John Wherry 2016-10-04
9333256 Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells Vijay K. Kuchroo, Laurent Monney, Jason L. Gaglia, Edward A. Greenfield, Hanspeter Waldner 2016-05-10
9102727 Human anti-PD-1 antibodies and uses therefor Rafi Ahmed, Timothy David Jones, Francis Joseph Carr, James P. Gregson 2015-08-11
8709412 Modulation of TIM receptor activity in combination with cytoreductive therapy Jennifer Jones, Rosemarie Dekruyff, Dale T. Umetsu, Susan Knox 2014-04-29
8697069 Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells Vijay K. Kuchroo, Laurent Monney, Jason L. Gaglia, Edward A. Greenfield, Hanspeter Waldner 2014-04-15
8652465 Methods and compositions for the treatment of persistent infections Arlene H. Sharpe, David M. Dorfman, Rafi Ahmed, Daniel Barber, E. John Wherry 2014-02-18
8552154 Anti-PD-L1 antibodies and uses therefor Rafi Ahmed, Timothy David Jones, Francis Joseph Carr, James P. Gregson 2013-10-08
8101176 Compositions and methods related to TIM-3, a TH1-specific cell surface molecule Vijay K. Kuchroo, Laurent Monney, Jason L. Gaglia, Edward A. Greenfield, Hanspeter Waldner 2012-01-24
8026224 Tumor cells with increased immunogenicity and uses therfor Suzanne Ostrand-Rosenberg, Sivasubramanina Baskar, Laurie H. Glimcher, Lee M. Nadler 2011-09-27
7838220 T cell regulatory genes associated with immune disease Jennifer Jones McIntire, Rosemarie Dekruyff, Dale T. Umetsu 2010-11-23
7722868 Agents that modulate the interaction of B7-1 polypeptide with PD-L1 and methods of use thereof Arlene H. Sharpe, Janet Buhlman, Didier Mandelbrot 2010-05-25